Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers

HER2 mutations are present in a subset of patients with lung cancer having distinct clinical features. HER2 mutations were not associated with the prognosis of patients with lung cancers. Patients with HER2 mutations might benefit from anti-HER2 therapy.